Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

Cancer Research

Pediatric Cancer

Hypoxia Markers and Their Importance

Cancer Prevention: Lowering your Risk

Metastatic Migration in Cancer may be Influenced by Metabolism

Cancer Pain Management

Transforming Cancer Care through Genomic Testing

Effects of Social and Economic Deprivation on Cancer Mortality

Cancer Pathophysiology

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

Secondary Lung Cancer

See more featured articles »

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Insight into Cancer Vaccines

Exploiting Enzymes in Cancer Diagnosis and Therapy

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

What is Merkel Cell Carcinoma?

Cancer Prognosis

What Role do Biobanks Play in Cancer Research?

Extracellular Vesicles as Floating Cancer Biomarkers

Myc Mutations and Cancer

Targeted Cancer Therapies

Microfluidic cancer treatment screen combined with flow cytometry

Cancer Pain

Caring for a Loved One with Cancer

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

What is Immunochemotherapy?

Cancer Diagnosis

British Pioneers in Cancer Biology

Cancer Glossary

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

Insights into Oncofertility

What is the Tumor Microenvironment?

Overview of Cell Viability and Cytotoxicity

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

Cancer Classification

Hot vs Cold: the differences between tumor types

Cutaneous Manifestations of Internal Malignancy

Using Biomarkers to Detect Cancer

Why are Cancer Cell Lines Useful?

The Effects of Cancer on Family Life

Acidosis and Tumor Progression

The Biochemistry of Breast Cancer Screening

Cancer Symptoms

What Causes Cancer?

Living with Cancer Pain

Cancer Screening Considerations: Balancing the Benefits and Risks

What is Cancer of Unknown Primary?

Secondary Brain Cancer

The Cancer Cell Surface Proteome as a Therapeutic Target

What is Cancer?

TARDIS: The Improved Method of Detecting Breast Cancer

What is Tumorigenesis?

Cancer Management

Assay for Monitoring and Treating Malignant Brain Tumors

Cancer Epidemiology

Investigating the Molecular Mechanisms of Cancer

Is Cancer a Metabolic Disorder?

CDK9 and Cancer

Cancer History

Latest Cancer News and Research

Researchers identify vulnerabilities shared by surviving cancer cells

Cancer drugs can shrink fast-growing tumors. But sometimes a few tumor cells survive. These "persister" cells seed new tumors, forcing cancer patients into arduous cycles of testing and treatment.

12 Jun 2026

FDA approves new adjuvant treatment option for ccRCC patients with recurrence risk

The U.S. Food and Drug Administration (FDA) has approved pembrolizumab, an immunotherapy, plus belzutifan, a HIF-2α inhibitor, as adjuvant treatment for adult patients with renal cell carcinoma with a clear cell component (ccRCC) at intermediate-high or high risk of recurrence following nephrectomy, with or without resection of metastatic lesions.

12 Jun 2026

Renowned physician‑scientist to lead Houston Methodist's cell and gene therapy research

Malcolm Brenner, an internationally recognized physician‑scientist renowned for his leadership in cell and gene therapy, has been tapped to lead the newly formed Houston Methodist Center for Cell and Gene Therapy.

12 Jun 2026

Major NIH grant helps establish the Oklahoma Center of ImmunoEngineering

The University of Oklahoma has received an $11.5 million award from the National Institutes of Health to establish the Oklahoma Center of ImmunoEngineering, a new research center designed to accelerate the study and treatment of diseases rooted in the immune system.

12 Jun 2026

Cellular process discovery may lead to new cancer treatments

A molecular geneticist at Montana State University has discovered a cellular process once believed impossible by scientists – the creation of the amino acid cysteine within a living cell when the cell's primary systems to do so fail. The discovery may one day lead to new cancer treatments.

12 Jun 2026

Novel metal-free prodrug suppresses cancer spread in preclinical models

A carefully designed metal-free carbon monoxide prodrug may help prevent some of the deadliest forms of cancer from spreading, according to researchers at Weill Cornell Medicine.

12 Jun 2026

New poll reveals political divide over public water fluoridation

As the debate over the value of adding fluoride to public drinking water percolates in communities across the nation, a new nationally representative survey from the Annenberg Public Policy Center (APPC) of the University of Pennsylvania finds Americans sharply divided over the use of fluoride in public drinking water.

12 Jun 2026

New genetic driver found for rare small intestinal cancers

A signaling system known as the Wnt pathway plays a central role in how cells in the intestine grow, divide, and renew themselves.

12 Jun 2026

Review outlines virtual tumor concept and next-generation immunotherapy

A comprehensive review led by Associate Researcher Linnan Zhu and Academician Zemin Zhang at Biomedical Pioneering Innovation Center (BIOPIC), Peking University, China, and Chongqing Medical University, China, was published in Volume 2, article number 27 of the journal Immunity & Inflammation on June 05, 2026.

12 Jun 2026

PhoreMost announces lead oncology program and appoints Chief Medical Officer to support clinical entry

PhoreMost Limited, a biotech company focused on turning scientific breakthroughs into life-changing cancer drugs, today announced its lead program, PMC-001, a next-generation, small molecule microtubule targeting agent (MTA) for primary and secondary brain cancers.

From PhoreMost 12 Jun 2026

New combination therapy improves outcomes in high-risk leukemia

A research team from the Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has developed a novel combination therapy that significantly improves treatment outcomes and survival in patients with acute myeloid leukaemia (AML) with FLT3 gene mutations.

11 Jun 2026

Scientists uncover protein-folding mechanism linked to diabetes progression

Origami masters turn simple sheets of paper into ornate sculptures. In the origami of life, our cells must fold proteins into specific three-dimensional shapes before they can carry out their biological jobs.

11 Jun 2026

Mesothelioma remains deadly despite declining asbestos exposure rates

Mesothelioma deaths and diagnoses continue to rise in the United States despite decades of asbestos regulation and reduced industrial use, according to a new national analysis from Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine.

11 Jun 2026

FemTech innovations are transforming women's health care worldwide

JMIR Publications released a News and Perspectives story on technological innovations in women's health care.

11 Jun 2026

Trial finds prunes do not outperform calcium and vitamin D for male bone density

A one-year randomized trial found that daily prune supplementation did not improve total or lumbar spine bone mineral density in older men susceptible to, or with, osteopenia. Although some bone turnover biomarkers differed between prune and control groups, these changes did not translate into measurable bone density benefits beyond calcium and vitamin D3 supplementation.

11 Jun 2026

FDA accepts immunotherapy drug for review in colon cancer treatment

The Alliance for Clinical Trials in Oncology (Alliance) today announced that the U.S. Food and Drug Administration has accepted for review Genentech's supplemental Biologic License Application for their immunotherapy drug atezolizumab (Tecentriq®) for the treatment of patients with stage III colon cancer with deficient deoxyribonucleic acid (DNA) mismatch repair (dMMR).

11 Jun 2026

Temple Health receives grant to launch family thriving program

Temple Health has been awarded a $700,000 three‑year grant from the William Penn Foundation to develop the Temple Family Thriving Program, a trauma‑informed initiative that integrates caregiver and early childhood support directly into prenatal and postpartum care.

11 Jun 2026

Collagen exists as liquid droplets inside living cells, study reveals

Collagen, the protein that builds skin, bones, tendons and organs, exists inside cells as a liquid-like droplet rather than the long, rigid rod seen in textbooks over the last half century, according to a new study from the Centre for Genomic Regulation (CRG) in Barcelona.

11 Jun 2026

USC hospitals earn top score for LGBTQ+ healthcare inclusion

Keck Medicine of USC hospitals and USC Student Health, part of Keck Medicine, received the LGBTQ+ Healthcare Equality Leader designation in the Human Rights Campaign Foundation's 2026 Healthcare Equality Index (HEI).

11 Jun 2026

Circadian clock protein BMAL1 enhances inflammatory responses in immune cells

Daily life is shaped by the solar day, influencing when we wake up, eat, work, and sleep. Inside the body, a similar internal timing system -present in nearly every cell- known as the circadian clock, synchronizes many biological functions such as sleep, metabolism, hormone release, and even the immune system's activity.

11 Jun 2026